Zimoxin for Cataract Surgery Prevention
JA
JA
JA
Overseen ByJason Ahee, M.D.
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 2 & 3
Waitlist Available
Sponsor: Jason Ahee, M.D.
Prior Safety Data
Approved in 2 Jurisdictions
Trial Summary
What is the purpose of this trial?
This trial tests if injecting an antibiotic called moxifloxacin into the eye after cataract surgery can prevent infections. Moxifloxacin is commonly used to prevent infections after cataract surgery. It targets patients who have had cataract surgery and aims to stop bacteria from causing infections.
Research Team
JA
Jason Ahee, M.D.
Principal Investigator
Zion Therapeutics, LLC
Eligibility Criteria
This trial is for individuals with visually significant cataracts who are undergoing surgery. It's not suitable for those allergic to fluoroquinolones or cobalamin (B12).Inclusion Criteria
I have cataracts that affect my vision significantly.
Exclusion Criteria
cobalamin (B12)
You are allergic to fluoroquinolones, a type of medication.
Treatment Details
Interventions
- Moxifloxacin (Fluoroquinolone Antibiotic)
Trial OverviewThe study tests the safety and effectiveness of an eye injection called Zimoxin, which contains moxifloxacin, to prevent infection after cataract surgery compared to a placebo.
Participant Groups
2Treatment groups
Active Control
Placebo Group
Group I: Treatment groupActive Control1 Intervention
Intracameral injection of moxifloxacin solution after cataract surgery
Group II: Placebo groupPlacebo Group1 Intervention
Intracameral injection of placebo after cataract surgery
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jason Ahee, M.D.
Lead Sponsor
Trials
1
Recruited
60,000+